Perioperative Aspirin Usage Survey

Use of Aspirin in the Perioperative Setting: A Surgeon's Survey

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02561507

Enrollment

150

Registered

2015-09-28

Start date

2015-10-31

Completion date

2016-05-31

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Surgery

Brief summary

This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.

Detailed description

An announcement of the survey and invitation to participate will be posted in the ACS Surgery News newsletter published by the American College of Surgeons. Surgeons of all specialties will be invited to participate. No identifiers will be maintained with survey responses. In addition to the substantive questions below, typical demographic data will be obtained including participants' duration of practice, specialty, gender, state, etc. The survey will include questions intended to characterize current practice surrounding the decision to continue or withhold aspirin in the perioperative period. Other questions will focus on surgeons' knowledge of national medical/surgical organizations that have published guidelines on the perioperative use of aspirin. Finally, other survey questions will characterize surgeons' knowledge of the platelet rebound effect.

Interventions

BEHAVIORALSurvey

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Members of the American College of Surgeons

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Typical proportion of participants' patients given a recommendation to stop taking aspirin	At time of survey; generally less than 20 minutes
Proportion of participants correctly identifying national organizations with perioperative aspirin recommendations	At time of survey; generally less than 20 minutes
Proportion of participants correctly answering questions about platelet rebound effect	At time of survey; generally less than 20 minutes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026